BCL2 |
P10415
|
BCL2 apoptosis regulator
|
Signaling
|
0.56 |
0.291 |
0.885 |
BMP2 |
P12643
|
bone morphogenetic protein 2
|
Signaling
|
0.99 |
0.432 |
0.846 |
BRAF |
P15056
|
B-Raf proto-oncogene, serine/threonine kinase
|
Kinase
|
1.00 |
0.319 |
0.846 |
CD34 |
P28906
|
CD34 molecule
|
|
5.0E-06 |
0.368 |
0.808 |
CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
CKAP4 |
Q07065
|
cytoskeleton associated protein 4
|
|
0.51 |
0.436 |
0.731 |
CTNNB1 |
P35222
|
catenin beta 1
|
|
1.00 |
0.303 |
0.885 |
FGF2 |
P09038
|
fibroblast growth factor 2
|
Signaling
|
1.8E-02 |
0.383 |
0.923 |
HIF1A |
Q16665
|
hypoxia inducible factor 1 subunit alpha
|
Transcription factor
|
0.98 |
0.327 |
0.923 |
HPSE |
Q9Y251
|
heparanase
|
Enzyme
|
2.3E-14 |
0.425 |
0.808 |
JAG2 |
Q9Y219
|
jagged canonical Notch ligand 2
|
|
1.00 |
0.576 |
0.846 |
KRAS |
P01116
|
KRAS proto-oncogene, GTPase
|
Enzyme modulator
|
7.9E-04 |
0.320 |
0.923 |
MMP9 |
P14780
|
matrix metallopeptidase 9
|
Enzyme
|
1.9E-17 |
0.305 |
0.923 |
MSC |
O60682
|
musculin
|
|
2.5E-02 |
0.475 |
0.846 |
MYC |
P01106
|
MYC proto-oncogene, bHLH transcription factor
|
Transcription factor
|
1.00 |
0.344 |
0.923 |
NOTCH1 |
P46531
|
notch receptor 1
|
|
1.00 |
0.369 |
0.885 |
NR0B1 |
P51843
|
nuclear receptor subfamily 0 group B member 1
|
Nuclear receptor
|
0.97 |
0.494 |
0.808 |
POU5F1 |
Q01860
|
POU class 5 homeobox 1
|
|
0.95 |
0.441 |
0.846 |
POU5F1P3 |
|
POU class 5 homeobox 1 pseudogene 3
|
|
|
0.452 |
0.808 |
POU5F1P4 |
|
POU class 5 homeobox 1 pseudogene 4
|
|
|
0.452 |
0.808 |
RPE65 |
Q16518
|
retinoid isomerohydrolase RPE65
|
Enzyme
|
6.5E-14 |
0.417 |
0.808 |
SOX2 |
P48431
|
SRY-box transcription factor 2
|
Transcription factor
|
0.71 |
0.405 |
0.808 |
TP53 |
P04637
|
tumor protein p53
|
Transcription factor
|
0.53 |
0.236 |
0.962 |
TP63 |
Q9H3D4
|
tumor protein p63
|
Transcription factor
|
1.00 |
0.362 |
0.769 |
UVRAG |
Q9P2Y5
|
UV radiation resistance associated
|
|
0.99 |
0.436 |
0.769 |